The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease
Abstract
CONTEXT: More than two decades have passed since members from the American Thyroid Association (ATA), European Thyroid Association, and Japan Thyroid Association were surveyed on management practices for patients with hyperthyroidism due to Graves' disease (GD). OBJECTIVE: We sought to document current practices in the management of GD and compare these results both to those documented in earlier surveys and to practice recommendations made in the 2011 ATA/American Association of Clinical Endocrinologists (AACE) hyperthyroidism practice guidelines. Lastly, we sought to examine differences in GD management among international members of U.S.-based endocrine societies. METHODS: Members of The Endocrine Society (TES), ATA, and AACE were invited to participate in a web-based survey dealing with testing, treatment preference, and modulating factors in patients with GD. RESULTS: A total of 730 respondents participated in the survey, 696 of whom completed all sections. Respondents included 641 TES members, 330 AACE members, and 157 ATA members. The preferred mode of therapy in uncomplicated GD was antithyroid drugs (ATDs) by 53.9% of respondents, radioactive iodine (RAI) therapy by 45.0%, and thyroid surgery in 0.7%. Compared with 1991, fewer U.S. (59.7 vs. 69%) and European (13.3% vs. 25%) respondents would use RAI therapy. Methimazole and carbimazole were the preferred ATDs, with only 2.7% of respondents selecting propylthiouracil. Patients with Graves' ophthalmopathy were treated with ATDs (62.9%) or surgery (18.5%) and less frequently with RAI plus corticosteroids (16.9%) or RAI alone (1.9%). CONCLUSIONS: Striking changes have occurred in the management of GD over the past two decades, with a shift away from RAI and toward ATDs in patients with uncomplicated GD. Apparent international differences persist but should be interpreted with caution. Current practices diverge in some areas from recently published guidelines; these differences should be assessed serially to determine the impact of the guidelines on future clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
TUNBRIDGE, W. M. G., EVERED, D. C., HALL, R., APPLETON, D., BREWIS, M., CLARK, F., EVANS, J. G., YOUNG, E., BIRD, T., & SMITH, P. A. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,674
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Cooper, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042972 · Cited by 1,008
Self-citationThe American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Self-citationRelation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
Pathogenesis of Graves' Ophthalmopathy
Epstein, F. H., Bahn, R. S., & Heufelder, A. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292007 · Cited by 605
Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428
WARTOFSKY, L., GLINOER, D., SOLOMON, B., NAGATAKI, S., LAGASSE, R., NAGAYAMA, Y., & IZUMI, M. (1991) · Thyroid · doi:10.1089/thy.1991.1.129 · Cited by 374
Current Trends in the Management of Graves' Disease*
SOLOMON, B., GLINOER, D., LAGASSE, R., & WARTOFSKY, L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1518 · Cited by 266
Träisk, F., Tallstedt, L., Abraham-Nordling, M., Andersson, T., Berg, G., Calissendorff, J., Hallengren, B., Hedner, P., Lantz, M., Nyström, E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0747 · Cited by 262
Bahn, R. S., Burch, H. S., Cooper, D. S., Garber, J. R., Greenlee, C. M., Klein, I. L., Laurberg, P., McDougall, I. R., Rivkees, S. A., Ross, D., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0169 · Cited by 223
Self-citationWalter, M. A., Briel, M., Christ-Crain, M., Bonnema, S. J., Connell, J., Cooper, D. S., Bucher, H. C., Müller-Brand, J., & Müller, B. (2007) · BMJ · doi:10.1136/bmj.39114.670150.be · Cited by 202
Self-citationMore on smoking habits and Graves’ ophthalmopathy
Bartalena, L., Martino, E., Marcocci, C., Bogazzi, F., Panicucci, M., Velluzzi, F., Loviselli, A., & Pinchera, A. (1989) · Journal of Endocrinological Investigation · doi:10.1007/bf03350047 · Cited by 199
Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children
Rivkees, S. A., & Szarfman, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2546 · Cited by 177
Increased cancer incidence after radioiodine treatment for hyperthyroidism
Metso, S., Auvinen, A. P., Huhtala, H., Salmi, J., Oksala, H., & Jaatinen, P. (2007) · Cancer · doi:10.1002/cncr.22635 · Cited by 161
Ending Propylthiouracil-Induced Liver Failure in Children
Rivkees, S. A., & Mattison, D. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0809750 · Cited by 140
Glinoer, D., Hesch, D., Lagasse, R., & Laurberg, P. (1987) · European Journal of Endocrinology · doi:10.1530/acta.0.115s006 · Cited by 117
Emiliano, A. B., Governale, L. A., Parks, M. A., & Cooper, D. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2752 · Cited by 112
Self-citationBurch, H. B., Solomon, B. L., Cooper, D. S., Ferguson, P., Walpert, N., & Howard, R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7639 · Cited by 110
Self-citationBraga, M., Walpert, N., Burch, H. B., Solomon, B. L., & Cooper, D. S. (2002) · Thyroid · doi:10.1089/105072502753522365 · Cited by 104
Self-citationA questionnaire survey on the management of Graves’ orbitopathy in Europe
_, _., Perros, P., Baldeschi, L., Boboridis, K. G., Dickinson, A. J., Hullo, A., Kahaly, G. J., Kendall-Taylor, P., Krassas, G. E., Lane, C., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02201 · Cited by 76
Discontinuing Antithyroid Drug Therapy before Ablation with Radioiodine in Graves Disease
Burch, H. B., Solomon, B. L., Wartofsky, L., & Burman, K. D. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-8-199410150-00001 · Cited by 55
Self-citation63 Years and 715 Days to the "Boxed Warning": Unmasking of the Propylthiouracil Problem
Rivkees, S. A. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/658267 · Cited by 51
The Management of Hyperthyroidism Due to Graves' Disease in Japan in 1988.
Nagayama, Y., Izumi, M., & Nagataki, S. (1989) · Endocrinologia Japonica · doi:10.1507/endocrj1954.36.299 · Cited by 47
Tominaga, T., Yokoyama, N., Nagataki, S., CHO, B. Y., Koh, C., CHEN, J.-L., & SHI, Y. (1997) · Thyroid · doi:10.1089/thy.1997.7.217 · Cited by 37
Management of Graves' disease in Australia
Walsh, J. P. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb00856.x · Cited by 27
Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years
Escobar‐Jiménez, F., Férnandez-Soto, M. L., Luna-López, V., Quesada‐Charneco, M., & Glinoer, D. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.896.340 · Cited by 21
Cited by
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“of respondents from the United States selected RAI as primary therapy for an uncomplicated case of GD, compared with 69% in a similar survey performed 20 years earlier (60).”
ResultSelf-citationSmith, T. J., & Hegedüs, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,257
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K., & Pearce, S. H. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 940
De Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Metadata
- Authors
- Burch, H. B., Burman, K. D., & Cooper, D. S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-12-01
- Volume
- 97
- Issue
- 12
- Pages
- 4549-4558
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2109826047
- Cited by
- 345
- References
- 30
- FWCI
- 12.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.